Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034619
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-05-01
Brief Title:
A Phase 2 Trial of ALIMTA LY231514 Pemetrexed Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer
Sponsor:
Organization:
Eli Lilly and Company